The Netherlands-based medical devices-focused CRO Factory has acquired Milestone Research Organization, expanding its footprint in North America.
“MileStone is an excellent fit therapeutically, as well as culturally,” said Factory CEO Dirk Meijer, M.D., Ph.D., in a statement. “Milestone’s extensive expertise in orthopedics, neurological and IVD clinical trials, as well as their reimbursement and site management service offerings, is a fantastic value-add for all our clients.”
What’s more, the addition of San Diego-based Milestone builds on Factory’s existing U.S. presence in Austin, Texas, and Princeton, New Jersey. Besides California, the company now has branches in Minnesota and the city of Chicago.
Operational in over 20 countries worldwide, Factory now offers medical device companies services in data management, consultancy regarding study design and budget and regulatory strategy, regulatory filings, clinical trial monitoring and reimbursement.
Since 1992, the company has completed more than 450 projects in Class II and Class III medical devices and in vitro diagnostic device (IVD), which span a wide range of therapeutic areas, including abdominal, cardiovascular, bone and joint and cardiothorax surgery, as well as interventional radiology, urology, diabetes and dermatology, etc.
According to Factory’s webpage, MileStone founder Kevin Liang, Ph.D., has transitioned to the role of chief clinical officer within the company.